Infinium Pharmachem
INFINIUMNSE

Infinium Pharmachem

₹208.00-2.20 (1.05%)1D
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Create Stock SIPAutomate your investments in this
Overview
Technicals
News
Events

Performance

Today’s low
208.00
Today’s high
218.40
52 week low
189.40
52 week high
337.00
Open price
218.00
Previous close
210.20
Live volume
6,000
Lower circuit
199.70
Upper circuit
220.70

Fundamentals

Market Cap
₹328Cr
ROE
8.14%
P/E Ratio(TTM)
41.79
EPS(TTM)
5.03
P/B Ratio
2.99
Dividend Yield
0.00%
Industry P/E
33.68
Book Value
70.25
Debt to Equity
0.00
Face Value
10

Financial performance

Quarterly
Yearly
All Financials
2025
Revenue (Cr)
₹158
+15.05%
Profit (Cr)
₹7.84
-31.82%
050100150200
2021
2022
2023
2024
2025
Revenue growthValue
3Y CAGR+16%
Profit growthValue
3Y CAGR+5%

About

Infinium Pharmachem Limited manufactures and supplies iodine derivatives and active pharmaceutical ingredients (APIs).;
CEO/MD
Sanjaykumar Viththalbhai Patel
Founded in
2003
NSE symbol
INFINIUM

Shareholding Pattern

Sep '24
Nov '24
Mar '25
Sep '25
Mar '26
Promoters
64.91%
Retail And Others
34.87%
Other Domestic Institutions
0.21%

Similar stocks

StockMkt price (1D)52 week performanceMarket capP/E ratioP/B ratio
Innova CaptabINNOVACAP
₹872.75
+1.70 (0.20%)
L
    H
    4,980.0037.614.88
    ₹378.20
    -4.55 (1.19%)
    L
      H
      4,170.1087.1815.77
      ₹414.00
      +11.20 (2.78%)
      L
        H
        3,765.7542.025.16
        Aarti DrugsAARTIDRUGS
        ₹400.45
        +9.10 (2.33%)
        L
          H
          3,568.2017.632.43
          Livesquawk
          Infinium Pharmachem opens a new plant for contrast media raw materials. The company targets approximately ₹100 crore in annual revenue from this venture.
          2025
          13
          Nov
          Result
          Release date
          Events calendar
          View upcoming events in other stocks